These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7429984)

  • 1. Microbial conversion of steffimycin and steffimycin B to 10-dihydrosteffimycin and 10-dihydrosteffimycin B.
    Wiley PF; Elrod DW; Slavicek JM; Marshall VP
    J Antibiot (Tokyo); 1980 Aug; 33(8):819-23. PubMed ID: 7429984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steffimycin C, a new member of the steffimycin anthracyclines. Isolation and structural characterization.
    Brodasky TF; Mizsak S; Hoffstetter JR
    J Antibiot (Tokyo); 1985 Jul; 38(7):849-55. PubMed ID: 3839781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial metabolism of anthracycline antibiotics. Steffimycinone and steffimycinol conversions.
    Wiley PF; Koert JM; Elrod DW; Reisender EA; Marshall VP
    J Antibiot (Tokyo); 1977 Aug; 30(8):649-54. PubMed ID: 20436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial conversion of epsilon-pyrromycinone to 1-hydroxy-11-deoxycarminomycin II.
    Nakagawa M; Hayakawa Y; Imamura K; Seto H; Otake N
    J Antibiot (Tokyo); 1985 Jun; 38(6):821-2. PubMed ID: 4019326
    [No Abstract]   [Full Text] [Related]  

  • 5. Reductive microbial conversion of anthracycline antibiotics.
    Marshall VP; Reisender EA; Reineke LM; Johnson JH; Wiley PF
    Biochemistry; 1976 Sep; 15(19):4139-45. PubMed ID: 786368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial conversion of epsilon-pyrromycinone and epsilon-isorhodomycinone to 1-hydroxy-13-dihydrodaunomcyin and N-formyl-1-hydroxy-13-dihydrodaunomycin and their bioactivities.
    Yoshimoto A; Matsuzawa Y; Oki T; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Oct; 33(10):1150-7. PubMed ID: 7451366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial conversion of anthracycline antibiotics. IV. Study on the glycosidation of epsilon-pyrromycinone by Streptomyces galilaeus OBB-111-848.
    Hoshino T; Fujiwara A
    J Antibiot (Tokyo); 1984 Nov; 37(11):1473-4. PubMed ID: 6511669
    [No Abstract]   [Full Text] [Related]  

  • 8. 4-O-(beta-D-Glucopyranosyl)-epsilon-rhodomycinone, a new microbial transformation product of rhodomycinone.
    Nakagawa M; Kawai H; Hayakawa Y; Seto H; Otake N
    J Antibiot (Tokyo); 1985 Nov; 38(11):1622-4. PubMed ID: 4077740
    [No Abstract]   [Full Text] [Related]  

  • 9. New anthracycline antibiotics obtained by microbial glycosidation of beta-isorhodomycinone and alpha 2-rhodomycinone.
    Yoshimoto A; Johdo O; Takatsuki Y; Ishikura T; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1984 Aug; 37(8):935-8. PubMed ID: 6592162
    [No Abstract]   [Full Text] [Related]  

  • 10. Mammalian and microbial cell-free conversion of anthracycline antibiotics and analogs.
    Rueckert PW; Wiley PF; McGovren JP; Marshall VP
    J Antibiot (Tokyo); 1979 Feb; 32(2):141-7. PubMed ID: 35508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical modification of steffimycin B.
    Wiley PF; Elrod DW; Harper DE
    J Antibiot (Tokyo); 1988 Mar; 41(3):343-51. PubMed ID: 3366692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and biological activity of marcellomycin, an antitumor anthracycline antibiotic, and taxonomy of the producing organism.
    Bush JA; Bradner WT; Tomita K
    J Antibiot (Tokyo); 1982 Sep; 35(9):1174-83. PubMed ID: 6754675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coloradocin, an antibiotic from a new Actinoplanes. I. Taxonomy, fermentation and biological properties.
    Jackson M; Karwowski JP; Theriault RJ; Fernandes PB; Semon RC; Kohl WL
    J Antibiot (Tokyo); 1987 Oct; 40(10):1375-82. PubMed ID: 3680003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antifungal antibiotics, benanomicins A and B from an actinomycete.
    Takeuchi T; Hara T; Naganawa H; Okada M; Hamada M; Umezawa H; Gomi S; Sezaki M; Kondo S
    J Antibiot (Tokyo); 1988 Jun; 41(6):807-11. PubMed ID: 3403377
    [No Abstract]   [Full Text] [Related]  

  • 15. Strong binding of ditrisarubicin B to DNA.
    Kunimoto S; Takahashi Y; Uchida T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1988 May; 41(5):655-9. PubMed ID: 3384751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 167-A, a new antibiotic produced by a mutant of an inactive wild strain of Amycolata autotrophica.
    Malkina ND; Dudnik YV; Lysenkova LN; Lazhko EI; Galatenko OA; Katrukha GS
    J Antibiot (Tokyo); 1994 Mar; 47(3):342-8. PubMed ID: 8175487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial conversion of anthracycline antibiotics. II. Characterization of the microbial conversion products of auramycinone by Streptomyces coeruleorubidus ATCC 31276.
    Hoshino T; Fujiwara A
    J Antibiot (Tokyo); 1983 Nov; 36(11):1463-7. PubMed ID: 6654755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Friulimicins: novel lipopeptide antibiotics with peptidoglycan synthesis inhibiting activity from Actinoplanes friuliensis sp. nov. I. Taxonomic studies of the producing microorganism and fermentation.
    Aretz W; Meiwes J; Seibert G; Vobis G; Wink J
    J Antibiot (Tokyo); 2000 Aug; 53(8):807-15. PubMed ID: 11079803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular structure of antitumor drug steffimycin and modelling of its binding to DNA.
    Sriram M; Liaw YC; Gao YG; Wang AH
    J Biomol Struct Dyn; 1991 Oct; 9(2):251-69. PubMed ID: 1741962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Demethoxy-3-ethoxy-tetracenomycin C.
    Lazar G; Zähner H; Breiding S; Damberg M; Zeeck A
    J Antibiot (Tokyo); 1981 Aug; 34(8):1067-8. PubMed ID: 7319920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.